These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33940518)

  • 1. Lipid nanocapsules co-encapsulating paclitaxel and salinomycin for eradicating breast cancer and cancer stem cells.
    Basu SM; Yadava SK; Singh R; Giri J
    Colloids Surf B Biointerfaces; 2021 Aug; 204():111775. PubMed ID: 33940518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.
    Valsalakumari R; Yadava SK; Szwed M; Pandya AD; Mælandsmo GM; Torgersen ML; Iversen TG; Skotland T; Sandvig K; Giri J
    Int J Pharm; 2021 Mar; 597():120217. PubMed ID: 33486035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles.
    Gao J; Liu J; Xie F; Lu Y; Yin C; Shen X
    Int J Nanomedicine; 2019; 14():9199-9216. PubMed ID: 32063706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin E-based redox-sensitive salinomycin prodrug-nanosystem with paclitaxel loaded for cancer targeted and combined chemotherapy.
    Liang DS; Liu J; Peng TX; Peng H; Guo F; Zhong HJ
    Colloids Surf B Biointerfaces; 2018 Dec; 172():506-516. PubMed ID: 30212688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.
    Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
    Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity.
    Zafar S; Akhter S; Garg N; Selvapandiyan A; Kumar Jain G; Ahmad FJ
    Eur J Pharm Biopharm; 2020 Mar; 148():10-26. PubMed ID: 31923585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An
    Radwan Y; Arafa KK; Ghoniem MG; Al-Farraj ES; El-Sherbiny IM
    Drug Dev Ind Pharm; 2023 Mar; 49(3):271-280. PubMed ID: 37067846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel.
    Muntimadugu E; Kumar R; Saladi S; Rafeeqi TA; Khan W
    Colloids Surf B Biointerfaces; 2016 Jul; 143():532-546. PubMed ID: 27045981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
    Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C
    Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced anti-tumor efficacy of paclitaxel with PEGylated lipidic nanocapsules in presence of curcumin and poloxamer: In vitro and in vivo studies.
    Anwar M; Akhter S; Mallick N; Mohapatra S; Zafar S; Rizvi MMA; Ali A; Ahmad FJ
    Pharmacol Res; 2016 Nov; 113(Pt A):146-165. PubMed ID: 27546165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel silk fibroin nanoparticles incorporated silk fibroin hydrogel for inhibition of cancer stem cells and tumor growth.
    Wu P; Liu Q; Wang Q; Qian H; Yu L; Liu B; Li R
    Int J Nanomedicine; 2018; 13():5405-5418. PubMed ID: 30271137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
    Roger E; Lagarce F; Garcion E; Benoit JP
    J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD44-Conjugated Olive Oil Liquid Nanocapsules for Targeting Pancreatic Cancer Stem Cells.
    Navarro-Marchal SA; Griñán-Lisón C; Entrena JM; Ruiz-Alcalá G; Tristán-Manzano M; Martin F; Pérez-Victoria I; Peula-García JM; Marchal JA
    Biomacromolecules; 2021 Apr; 22(4):1374-1388. PubMed ID: 33724003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.
    Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z
    Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid- and TPGS-Based Core-Shell-Type Nanocapsules Endowed with High Paclitaxel Loading and Enhanced Anticancer Potential.
    Katiyar SS; Patil R; Ghadi R; Kuche K; Kushwah V; Dora CP; Jain S
    AAPS PharmSciTech; 2022 Aug; 23(7):238. PubMed ID: 36002600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery.
    Groo AC; Saulnier P; Gimel JC; Gravier J; Ailhas C; Benoit JP; Lagarce F
    Int J Nanomedicine; 2013; 8():4291-302. PubMed ID: 24235827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy.
    Narayanaswamy R; Torchilin VP
    Pharm Res; 2021 Mar; 38(3):429-450. PubMed ID: 33655395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells.
    Yang Z; Sun N; Cheng R; Zhao C; Liu Z; Li X; Liu J; Tian Z
    Biomaterials; 2017 Dec; 147():53-67. PubMed ID: 28930649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel and Erlotinib-co-loaded Solid Lipid Core Nanocapsules: Assessment of Physicochemical Characteristics and Cytotoxicity in Non-small Cell Lung Cancer.
    Gupta B; Poudel BK; Regmi S; Pathak S; Ruttala HB; Gautam M; An GJ; Jeong JH; Choi HG; Yong CS; Kim JO
    Pharm Res; 2018 Mar; 35(5):96. PubMed ID: 29536182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.